Deutsche Bank Ag\ Volitionrx LTD Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$3.01 - $3.78 $75,602 - $94,942	-25,117 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$3.33 - $6.5 $1,794 - $3,503	539 Added 2.19%	25,117 $94,000
Q4 2020 Feb 16, 2021	BUY	$2.88 - $4.33 $31,317 - $47,084	10,874 Added 79.35%	24,578 $96,000
Q3 2020 Nov 12, 2020	BUY	$2.94 - $4.05 $8,478 - $11,680	2,884 Added 26.65%	13,704 $44,000
Q2 2020 Aug 13, 2020	BUY	$2.89 - $4.32 $31,269 - $46,742	10,820 New	10,820 $42,000
Q1 2020 May 14, 2020	SELL	$2.47 - $5.16 $9,880 - $20,640	-4,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.28 - $5.95 $1,853 - $2,576	433 Added 12.14%	4,000 $18,000
Q3 2019 Nov 14, 2019	BUY	$2.97 - $6.42 $10,593 - $22,900	3,567 New	3,567 $20,000

17.8M

41K

100

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $39.5M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.